The serum levels of klotho (KL) decrease in CKD patients with heart valve calcification and therefore klotho is considered an independent risk factor for CAVD in CKD (7). The gene discussed is KL; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.